openPR Logo
Press release

Small Molecule API Market Poised to Register At 4.9% CAGR Through 2027 | ohnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis AG, Bristol-Myers Squibb

02-01-2019 08:32 AM CET | Health & Medicine

Press release from: Future Market Insights

Small Molecule API Market Poised to Register At 4.9% CAGR Through

A FMI study titled “Small Mole API Market” has highlighted that small molecule APIs continue to dominate the pharmaceutical market with fast U.S. FDA approvals for small molecule APIs in 2017. Small molecules are chemical substances composed of two or more atoms with molecular weight of less than 900 Dalton. In this report, the small molecule API segment is further categorized into standard API and high potency APIs. The U.S. FDA approved 34 new small molecule API entities in 2017. Growing accessibility to drugs and essential healthcare are fuelling the demand for small molecule API entities globally. Capacity of manufacturing is the single most important factor that holds back revenue the growth of the small molecule API market. Other restraining factors of the small mole API market include faulty standards in quality, flexibility of manufacturing, customer service and reliability.

Request to View a Sample Copy of This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4591

Industry leader Cambrex believes that the small molecule API market is witnessing an all-time high growth. The small molecule API market is large, very fragmented and there is growing trend of outsourcing. The major manufacturers of small molecule API note that the outsourced market accounts for over 50% of the small molecule API market in revenue terms. The small molecule API manufacturers are present mostly in North America, Europe and Asia Pacific. So are the contract manufacturers for small molecule APIs.

Small molecule APIs constitute ~65% of all pipeline drugs under development with leading drug regulators. Small molecule APIs in development have increased by 6% in 2017 over 2016. Small molecule APIs are rapidly advancing into late stages of development, which is increasing the demand for fill-finish contract manufacturing organizations. Furthermore, contract manufacturing and developing organizations specialized in small molecule APIs are making strategic investments to expand their service offerings for big clients. For example, contract manufacturing organizations are becoming a “one-stop-shop” for both small molecule APIs and finished forms in development and commercialization. This helps to maximize the synergy derived from the deals for more strategic partnerships between small molecule API manufacturers and others to keep predicting volumes and manufacturing requirements in check and visibility from an early stage. Pharma companies benefit when they are able to source small molecule APIs and finished dosage from a single CMO/CDMO. This minimizes the cost and complexity of the overall product, potentially reducing the time to market.

Increasing competition from local players is deterring the manufacturing of small molecule APIs. High competition from local small molecule API manufacturers is influencing the growth of the small molecule API market and is affecting the quality of the small molecule API produced. Increasing competition from local small molecule API manufacturers in terms of price is ultimately decreasing the profitability of multinational branded small molecule API manufacturers including small molecule manufacturing CMOs. As result, the captive small molecule API manufacturers are losing grounds in the Asian countries. These companies are facing challenges in terms of profitability and product margins.

Read Comprehensive Overview with Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-4591

Changing regulatory dynamics are hampering the growth of the small molecule API market. Supply chain security issues, facility contamination issues that could alter potency levels of small molecule APIs are leading to facility closures across emerging countries. This has a large impact on the cost of finished dosages of these small molecule APIs. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges owing to aforementioned factors. This makes the market entry a costly decision for small and medium small molecule API manufacturers and contract manufacturing organizations. Such changing regulatory dynamics are hampering the growth of the small molecule API market in emerging countries.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Small Molecule API Market Poised to Register At 4.9% CAGR Through 2027 | ohnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis AG, Bristol-Myers Squibb here

News-ID: 1552618 • Views: 334

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for API

Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our